Zidovudine (AZT) . Current state of the development
Kouzan, S.; Nebout, T.
Annales de Medecine Interne 142(6): 444-455
1991
ISSN/ISBN: 0003-410X PMID: 1772186 Document Number: 367954
Document emailed within 1 workday
Related Documents
Cibulka, J. 2014: Contraceptive vaccinogen - current state of development Ceska Gynekologie 79(1): 12-15Shternberg, E.I. 1974: The development and current state of psychiatric syndromology Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 74(11): 1723-1736
Kharchenko, V.P.; Rozhkova, N.I. 2009: Current state and perspectives of the development of radiology service in Russia Voprosy Onkologii 55(4): 416-423
Petrov, I.N. 1977: Current state and perspectives of development of the control of non-pulmonary tuberculosis Problemy Tuberkuleza 1977(4): 8-11
Naumenko, V.G.; Naĭnis, I.V.; Sundukov, V.A.; Shagylydzhov, K.Sh. 1982: Current state and prospects for development of research in the field of forensic thanatology Sudebno-Meditsinskaia Ekspertiza 25(3): 11-14
Ivanetz, N.N.; Tikhonova, Y.G.; Kinkulkina, M.A.; Avdeeva, T.I. 2014: Treatment of depression: the current state and perspectives of the development of pharmacological studies Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(10): 108-116
Marmur, R.K.; Moiseeva, N.N.; Korkhov, S.S. 1979: Current state and perspectives of further development of phonophoresis of drugs in ophthalmology (review of the literature) Oftalmologicheskii Zhurnal 34(2): 68-73
Mehl, A.; Hickel, R. 1999: Current state of development and perspectives of machine-based production methods for dental restorations International Journal of Computerized Dentistry 2(1): 9-35
Moyle, G.J. 2005: The role of zidovudine in development of lipoatrophy Aids Reader 15(11): 591
Mays, D.C.; Dixon, K.F.; Balboa, A.; Pawluk, L.J.; Bauer, M.R.; Nawoot, S.; Gerber, N. 1991: A nonprimate animal model applicable to zidovudine pharmacokinetics in humans: inhibition of glucuronidation and renal excretion of zidovudine by probenecid in rats Journal of Pharmacology and Experimental Therapeutics 259(3): 1261-1270
Dolin, R.; Amato, D.A.; Fischl, M.A.; Pettinelli, C.; Beltangady, M.; Liou, S.H.; Brown, M.J.; Cross, A.P.; Hirsch, M.S.; Hardy, W.D. 1995: Zidovudine compared with didanosine in patients with advanced HIV type 1 infection and little or no previous experience with zidovudine. AIDS Clinical Trials Group Archives of Internal Medicine 155(9): 961-974
Lertcheewakarn, P.; Tongprasert, F. 2014: A comparison of maternal anemia between HIV infected pregnant women receiving zidovudine-based and zidovudine-free highly active Antiretroviral therapy (HAART) Journal of the Medical Association of Thailand 97(4): 361-368
Stojanov, R.; Bureš, O.; Duží, B. 2017: Migration and development policies: the state of affairs before the 2015 European migration crises in the Czech Republic and its current implications Communist and Post-Communist Studies 50(3): 169-181
Lopez-Anaya, A.; Unadkat, J.D.; Schumann, L.A.; Smith, A.L. 1990: Pharmacokinetics of zidovudine (azidothymidine). II. Development of metabolic and renal clearance pathways in the neonate Journal of Acquired Immune Deficiency Syndromes 3(11): 1052-1058
Staszewski, S.; Keiser, P.; Montaner, J.; Raffi, F.; Gathe, J.; Brotas, V.; Hicks, C.; Hammer, S.M.; Cooper, D.; Johnson, M.; Tortell, S.; Cutrell, A.; Thorborn, D.; Isaacs, R.; Hetherington, S.; Steel, H.; Spreen, W. 2001: Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial JAMA 285(9): 1155-1163
Katlama, C.; Ingrand, D.; Loveday, C.; Clumeck, N.; Mallolas, J.; Staszewski, S.; Johnson, M.; Hill, A.M.; Pearce, G.; McDade, H. 1996: Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. a randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group JAMA 276(2): 118-125
Gartland, M. 2001: AVANTi 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients Antiviral Therapy 6(2): 127-134
Zijenah, L.S.; Kadzirange, G.; Rusakaniko, S.; Kufa, T.; Gonah, N.; Tobaiwa, O.; Gwanzura, C.; Matsikire, E.; Katzenstein, D.A. 2006: A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe Central African Journal of Medicine 52(1-2): 1-8
Goodgame, J.C.; Pottage, J.C.; Jablonowski, H.; Hardy, W.D.; Stein, A.; Fischl, M.; Morrow, P.; Feinberg, J.; Brothers, C.H.; Vafidis, I.; Nacci, P.; Yeo, J.; Pedneault, L. 2000: Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team Antiviral Therapy 5(3): 215-225
Moolasart, P.; Likanonsakul, S. 2002: The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children Southeast Asian Journal of Tropical Medicine and Public Health 33(2): 280-287